Table 2 KEGG analysis of differentially expressed genes in PrxII+/+ (WT) and PrxII−/−
Path ID | Pathway | Count | p-value |
|---|---|---|---|
mmu04612 | Antigen processing and presentation | 13 | 3.95E−11 |
mmu05160 | Hepatitis C | 13 | 3.04E−08 |
mmu04623 | Cytosolic DNA-sensing pathway | 9 | 4.74E−08 |
mmu05330 | Allograft rejection | 9 | 4.74E−08 |
mmu05332 | Graft-versus-host disease | 9 | 6.51E−08 |
mmu04940 | Type I diabetes mellitus | 9 | 1.37E−07 |
mmu05320 | Autoimmune thyroid disease | 9 | 4.46E−07 |
mmu05416 | Viral myocarditis | 9 | 3.99E−06 |
mmu04145 | Phagosome | 12 | 4.60E−06 |
mmu04620 | Toll-like receptor signaling pathway | 9 | 7.92E−06 |
mmu04622 | RIG-I-like receptor signaling pathway | 7 | 3.68E−05 |
mmu04514 | Cell adhesion molecules (CAMs) | 10 | 4.01E−05 |
mmu05150 | Staphylococcus aureus infection | 6 | 5.87E−05 |
mmu04610 | Complement and coagulation cascades | 7 | 6.91E−05 |
mmu04144 | Endocytosis | 11 | 1.97E−04 |
mmu03050 | Proteasome | 4 | 3.11E−03 |
mmu04062 | Chemokine signaling pathway | 8 | 3.99E−03 |
mmu05322 | Systemic lupus erythematosus | 7 | 4.44E−03 |
mmu04060 | Cytokine-cytokine receptor interaction | 9 | 5.96E−03 |
mmu04621 | NOD-like receptor signaling pathway | 4 | 7.74E−03 |
mmu05340 | Primary immunodeficiency | 3 | 1.07E−02 |
mmu00603 | Glycosphingolipid biosynthesis—globo series | 2 | 1.71E−02 |
mmu04380 | Osteoclast differentiation | 5 | 2.18E−02 |
mmu02010 | ABC transporters | 3 | 2.28E−02 |